Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Dolby Laboratories
(NYSE:DLB)
Intraday
$79.58
0.42
[0.53%]
After-Hours
$79.58
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$79.58
0.42
[0.53%]
At close: Apr 24
$79.58
0
[0.00%]
After Hours: 4:20PM EDT
Get Report
Watch
Q2 2024 Earnings in 8 days from now on Thu May 2nd, after the market close
Conference call scheduled in 8 days at 17:00 PM
Click to view the webcast
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Dolby Laboratories Stock (NYSE:DLB)
Dolby Laboratories Stock (NYSE: DLB)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, February 22, 2024
Dolby Laboratories Exceeds Expectations with Strong Performance, Driving Profits and Rewarding Investors
Benzinga Insights
-
Feb 22, 2024, 10:05AM
Wednesday, February 07, 2024
Dolby Laboratories: Dividend Insights
Benzinga Insights
-
Feb 7, 2024, 9:45AM
Friday, February 02, 2024
Why Skechers Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
-
Feb 2, 2024, 1:18PM
Thursday, February 01, 2024
Dolby Laboratories: Q1 Earnings Insights
Benzinga Insights
-
Feb 1, 2024, 4:20PM
Dolby Laboratories Q1 Adj EPS $1.01 Beats $0.86 Estimate, Sales $315.57M Beat $312.87M Estimate
Benzinga Newsdesk
-
Feb 1, 2024, 4:16PM
Earnings Scheduled For February 1, 2024
Benzinga Insights
-
Feb 1, 2024, 5:03AM
Wednesday, January 31, 2024
Earnings Outlook For Dolby Laboratories
Benzinga Insights
-
Jan 31, 2024, 1:02PM
Rosenblatt Reiterates Buy on Dolby Laboratories, Maintains $98 Price Target
Benzinga Newsdesk
-
Jan 31, 2024, 7:47AM
Monday, December 11, 2023
Rosenblatt Reiterates Buy on Dolby Laboratories, Maintains $98 Price Target
Benzinga Newsdesk
-
Dec 11, 2023, 10:44AM
Tuesday, December 05, 2023
Commitment to Shareholders amid Decreased Earnings: Dolby Laboratories Ensures Steady Distribution
Benzinga Insights
-
Dec 5, 2023, 10:05AM
Wednesday, November 22, 2023
Dolby Laboratories: Dividend Insights
Benzinga Insights
-
Nov 22, 2023, 9:45AM
Friday, November 17, 2023
Why Dolby Laboratories Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
Nov 17, 2023, 1:01PM
Dolby shares are trading lower after the company issued weak Q1 and FY4 guidance.
Benzinga Newsdesk
-
Nov 17, 2023, 12:37PM
Rosenblatt Reiterates Buy on Dolby Laboratories, Maintains $98 Price Target
Benzinga Newsdesk
-
Nov 17, 2023, 8:44AM
12 Information Technology Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Nov 17, 2023, 8:06AM
Thursday, November 16, 2023
Weak Q1, FY24 Guidance Dampens Dolby Laboratories' Q4 Earnings Beat
Ryan Gustafson
-
Nov 16, 2023, 5:17PM
Dolby Sees Q1 Adj. EPS $0.80-$0.95 vs $1.08 Est., Total Revenue $300M-$330M vs $353.67M Est.; Sees FY24 Adj. EPS $3.60-$3.75 vs $3.77 Est., Total Revenue ~$1.3B vs $1.36B Est.
Benzinga Newsdesk
-
Nov 16, 2023, 4:22PM
Dolby Laboratories Q4 Adj $0.65 Beats $0.53 Estimate, Sales $290.56M Beat $290.20M Estimate
Benzinga Newsdesk
-
Nov 16, 2023, 4:21PM
Recap: Dolby Laboratories Q4 Earnings
Benzinga Insights
-
Nov 16, 2023, 4:20PM
Earnings Scheduled For November 16, 2023
Benzinga Insights
-
Nov 16, 2023, 5:14AM
Wednesday, November 15, 2023
Dolby Laboratories's Earnings Outlook
Benzinga Insights
-
Nov 15, 2023, 10:01AM
Monday, August 28, 2023
Transforming TV Sound: Dolby Atmos FlexConnect Debuts In TCL's 2024 Lineup
Nabaparna Bhattacharya
-
Aug 28, 2023, 1:09PM
Friday, August 18, 2023
12 Information Technology Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Aug 18, 2023, 1:31PM
Dolby Laboratories shares are trading higher after it was announced the company will join the S&P MidCap 400.
Benzinga Newsdesk
-
Aug 18, 2023, 11:06AM
Dolby Laboratories To Replace Staar Surgical In S&P MidCap 400; Staar Surgical To Replace Urstardt Biddle Properties In S&P SmallCap 600
Benzinga Newsdesk
-
Aug 18, 2023, 9:27AM
12 Information Technology Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Aug 18, 2023, 9:05AM
Thursday, August 17, 2023
12 Information Technology Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Aug 17, 2023, 5:32PM
Tuesday, August 08, 2023
Dolby Laboratories's Ex-Dividend Date Is Friday, Here's What You Need To Know
Benzinga Insights
-
Aug 8, 2023, 10:45AM
Top 5 Tech Stocks Which Could Rescue Your Portfolio This Month
Lisa Levin
-
Aug 8, 2023, 8:40AM
Friday, August 04, 2023
Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
Aug 4, 2023, 12:55PM
Dolby Laboratories shares are trading lower following a Q3 revenue miss.
Benzinga Newsdesk
-
Aug 4, 2023, 12:42PM
Rosenblatt Maintains Buy on Dolby Laboratories, Raises Price Target to $98
Benzinga Newsdesk
-
Aug 4, 2023, 8:53AM
Thursday, August 03, 2023
Dolby Laboratories Q3 EPS $0.55, Inline, Sales $298.37M Miss $301.65M Estimate
Benzinga Newsdesk
-
Aug 3, 2023, 4:45PM
Dolby Laboratories Q3 Adj EPS $0.55, Inline, Sales $298.37M Miss $301.65M Estimate
Benzinga Newsdesk
-
Aug 3, 2023, 4:35PM
Earnings Scheduled For August 3, 2023
Benzinga Insights
-
Aug 3, 2023, 6:59AM
Friday, July 28, 2023
Rosenblatt Reiterates Buy on Dolby Laboratories, Maintains $93 Price Target
Benzinga Newsdesk
-
Jul 28, 2023, 8:05AM
Monday, June 12, 2023
Dolby Laboratories Extends Multi-Year Agreement With Cinépolis
Akanksha Bakshi
-
Jun 12, 2023, 10:53AM
Thursday, June 01, 2023
Rosenblatt Reiterates Buy on Dolby Laboratories, Maintains $93 Price Target
Benzinga Newsdesk
-
Jun 1, 2023, 7:07AM
Wednesday, May 17, 2023
Dolby Laboratories's Return on Invested Capital Overview
Benzinga Insights
-
May 17, 2023, 10:47AM
Wednesday, May 10, 2023
Dolby Laboratories: Dividend Insights
Benzinga Insights
-
May 10, 2023, 10:45AM
Thursday, May 04, 2023
Recap: Dolby Laboratories Q2 Earnings
Benzinga Insights
-
May 4, 2023, 4:45PM
Dolby Sees FY23 Adj. EPS $3.15-$3.65 vs $3.43 Est., Total Revenue $1.27B-$1.33B vs $1.29B Est.
Benzinga Newsdesk
-
May 4, 2023, 4:36PM
Dolby Laboratories Q2 Adj. EPS $1.26 Beats $0.97 Estimate, Sales $375.90M Beat $349.84M Estimate
Benzinga Newsdesk
-
May 4, 2023, 4:35PM
Earnings Scheduled For May 4, 2023
Benzinga Insights
-
May 4, 2023, 6:34AM
Wednesday, May 03, 2023
Dolby Laboratories's Earnings: A Preview
Benzinga Insights
-
May 3, 2023, 1:03PM
Wednesday, April 26, 2023
Rosenblatt Reiterates Buy on Dolby Laboratories, Maintains $90 Price Target
Benzinga Newsdesk
-
Apr 26, 2023, 7:13AM
Friday, April 14, 2023
Tigress Financial Reiterates Buy on Dolby Laboratories, Maintains $116 Price Target
Benzinga Newsdesk
-
Apr 14, 2023, 10:49AM
Wednesday, February 08, 2023
Friday Is Your Last Chance To Buy Dolby Laboratories Before The Dividend Payout
Benzinga Insights
-
Feb 8, 2023, 9:45AM
Tuesday, February 07, 2023
Dolby Laboratories's Return on Invested Capital Insights
Benzinga Insights
-
Feb 7, 2023, 9:46AM
Friday, February 03, 2023
Rosenblatt Maintains Buy on Dolby Laboratories, Raises Price Target to $90
Benzinga Newsdesk
-
Feb 3, 2023, 8:26AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch